PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials
The metabolic/cell signaling basis of Warburg’s effect (“aerobic glycolysis”) and the general metabolic phenotype adopted by cancer cells are first reviewed. Several bypasses are adopted to provide a panoramic integrated view of tumoral metabolism, by attributing a central signaling role to hypoxia-...
Saved in:
| Main Authors: | Joseph Vamecq, Jean-Marie Colet, Jean Jacques Vanden Eynde, Gilbert Briand, Nicole Porchet, Stéphane Rocchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2012/304760 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARs and Anticancer Therapies
by: Michael E. C. Robbins, et al.
Published: (2010-01-01) -
Aby Warburg’s Impresa
by: Davide Stimilli
Published: (2013-01-01) -
Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia
by: Hongpeng Duan, et al.
Published: (2024-12-01) -
Moving Memory: The Buildings of the Warburg Institute
by: Tim Ainsworth Anstey
Published: (2020-01-01) -
Walker-Warburg syndrome: report of two cases
by: VASCONCELOS MARCIO M., et al.
Published: (1999-01-01)